aDepartment of Pharmacology, Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hengyang Medical School

bDepartment of Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China

Received 30 October 2022 Revised form accepted 30 November 2022.

*Zong-bao Wang and Shu-zhi Wang are co-corresponding authors.

Correspondence to Shu-zhi Wang, PhD, Department of Pharmacology, Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang 421001, China, Tel: (+086) 0734-828 2914; e-mail: [email protected]